This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignees: Novartis Ag, Ottawa Health Research Institute. Active years: 2005.
Company Filing History:
1 out of 3,975 
1 out of 12 Years Active: 2005
Title: Rachel Jane Ritchie: Innovator in Aquatic Health
Introduction
Rachel Jane Ritchie is a prominent inventor based in Fredericton, Canada. She has made significant contributions to the field of aquatic health, particularly in the development of vaccines for fish. Her innovative work focuses on combating infectious diseases that affect aquatic life.
Latest Patents
Ritchie holds a patent for "Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their uses as vaccines." This invention provides a method for using nucleic acid sequences and amino acid sequences to prepare vaccines that protect fish against the infectious salmon anaemia virus (ISAV). The vaccine incorporates peptide sequences that induce an immune response to the surface antigens of ISAV, thereby offering a protective strategy for fish health.
Career Highlights
Throughout her career, Rachel has worked with notable organizations such as Novartis Ag and the Ottawa Health Research Institute. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Ritchie has collaborated with esteemed colleagues, including Steven Gareth Griffiths and Joel Heppell. These partnerships have enhanced her research efforts and broadened the impact of her work in the field of aquatic health.
Conclusion
Rachel Jane Ritchie is a trailblazer in the development of vaccines for fish, demonstrating her commitment to improving aquatic health through innovative research. Her contributions are vital for the protection of fish against infectious diseases, showcasing the importance of scientific advancements in this area.